CRRT fluids

Ci-Ca® Dialysate Plus solution bag

Solutions for cleaning the blood

  • Consistent 5-liter bag format
  • Ready to use convenient handling
  • CRRT solutions 100% bicarbonate or lactate buffered

Key Features

Bicarbonate buffered CRRT solutions

*Depending on local product approval

Phosphate-containing CRRT solutions

Possible clinical results of hypophosphatemia:1

  • Apnea
  • Limitation of cardiac capacity
  • Leukocyte failure
  • Rhabdomyolysis
  • Hemolysis
  • Diabetic ketoacidosis
  • CNS dysfunction

Lactate solutions

*Depending on local product approval

Ci-Ca® Dialysate

Ci-Ca® Dialysate K2 / K4

*Depending on local product approval

Ci-Ca® Dialysate Plus

  • Ci-Ca® Dialysate Plus — Easing phosphate management
  • Fully integrated citrate anticoagulation with multiFiltrate Ci-Ca®
  • Virtually interruption-free CRRT: High efficacy & easy handling
  • Inherent stabilization of serum phosphate concentration

multiBic®

multiBic® – Always the right solution

Sophisticated and convenient — The multiBic® 5 liter bag has many advantages

multiBic® at a glance

multiPlus

multiPlus – CRRT solution with phosphate

Preventing the formation of Hypophosphatemia

The advantages at a glance

  • Inherent stabilization of serum phosphate concentration
  • Prevents the formation of hypophosphatemia and results in normalization of the serum phosphate concentration
  • Phosphate and glucose ensure the adequate provision of energy rich components for metabolic processes
  • Reliability and cost efficiency – separate phosphate substitution is unnecessary
  • Simple handling due to the 5 liter dual chamber bag

multiLac®

multiLac® – Clear line lactate buffered hemofiltration solutions

Prescribing Information

Abbreviated Prescribing Information for multiBic® solution

PDF, 52.7 KB

Abbreviated Prescribing Information for multiBic® solution

PDF, 52.7 KB

Abbreviated Prescribing Information for multiBic® solution

PDF, 52.7 KB

Downloads

Related content

1 Amanzadeh J. & Reilly RF Jr., Nature Clinical Practice Nephrology (2006); 2: 136 - 148
2 Lentz R. et al., Annals of Internal Medicine (1978); 89: 941 - 944
3 Gatchalian R. et al., American Journal of Kidney Diseases (2000); 36: 1262 - 1266
4 Zazzo J. et al., Intensive Care Med (1995); 21: 826 - 831
5 Shor R. et al., Annals of Clinical & Laboratory Science (2006); 36: 67 - 72
6 Schwartz A. et al., European Journal of Internal Medicine (2002); 13: 434 - 438